4//SEC Filing
ROBINS CHAD M 4
Accession 0001780649-26-000001
CIK 0001478320other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 8:30 PM ET
Size
5.5 KB
Accession
0001780649-26-000001
Insider Transaction Report
Form 4
ROBINS CHAD M
DirectorCEO and Chairman
Transactions
- Sale
Common Stock
2026-01-05$15.59/sh−124,998$1,948,719→ 2,584,243 total
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2025.
- [F2]The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.31 to $15.96, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.
Documents
Issuer
Adaptive Biotechnologies Corp
CIK 0001478320
Entity typeother
Related Parties
1- filerCIK 0001780649
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 8:30 PM ET
- Size
- 5.5 KB